BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10699611)

  • 1. Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt.
    van Rhijn BW; van der Poel HG; Boon ME; Debruyne FM; Schalken JA; Witjes JA
    Urology; 2000 Mar; 55(3):363-7. PubMed ID: 10699611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quanticyt: karyometric analysis of bladder washing for patients with superficial bladder cancer.
    van der Poel HG; Witjes JA; van Stratum P; Boon ME; Debruyne FM; Schalken JA
    Urology; 1996 Sep; 48(3):357-64. PubMed ID: 8804485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
    Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave-antigen retrieval for proliferation analysis (MIB-1) and quanticyt karyometry of bladder washings.
    Van der Poel HG; Boon ME
    Eur J Morphol; 1994 Mar; 32(1):71-8. PubMed ID: 8086270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting disease outcome of non-invasive transitional cell carcinoma of the urinary bladder using an artificial neural network model: results of patient follow-up for 15 years or longer.
    Fujikawa K; Matsui Y; Kobayashi T; Miura K; Oka H; Fukuzawa S; Sasaki M; Takeuchi H; Okabe T
    Int J Urol; 2003 Mar; 10(3):149-52. PubMed ID: 12622711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural network-based digitized cell image diagnosis of bladder wash cytology.
    Vriesema JL; van der Poel HG; Debruyne FM; Schalken JA; Kok LP; Boon ME
    Diagn Cytopathol; 2000 Sep; 23(3):171-9. PubMed ID: 10945904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer.
    Van der Poel HG; Van Balken MR; Schamhart DH; Peelen P; de Reijke T; Debruyne FM; Schalken JA; Witjes JA
    Urology; 1998 Jan; 51(1):44-50. PubMed ID: 9457287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
    Shariat SF; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Sawczuk I; Serretta V; Huland H; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Wians F; Roehrborn CG; Lotan Y; Perrotte P; Benayoun S; Marberger MJ; Karakiewicz PI
    J Urol; 2005 May; 173(5):1518-25. PubMed ID: 15821471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
    Konety BR; Metro MJ; Melham MF; Salup RR
    Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
    Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
    Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of fluorescence in situ hybridization for diagnosis and surveillance of bladder urothelial carcinoma.
    Huang JW; Mu JG; Li YW; Gan XG; Song LJ; Gu BJ; Fu Q; Xu YM; An RH
    Urol J; 2014 Nov; 11(6):1974-9. PubMed ID: 25433477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma.
    Bernardini S; Billerey C; Martin M; Adessi GL; Wallerand H; Bittard H
    J Urol; 2001 Jan; 165(1):42-6; discussion 46. PubMed ID: 11125360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-invasive urinary diagnosis of bladder cancer. What do we know?].
    Kausch I; Böhle A
    Urologe A; 2003 Jul; 42(7):912-21. PubMed ID: 12898034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis.
    Raab SS; Lenel JC; Cohen MB
    Cancer; 1994 Sep; 74(5):1621-6. PubMed ID: 8062194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy.
    Lodde M; Mayr R; Martini T; Comploj E; Palermo S; Trenti E; Hanspeter E; Fritsche HM; Mian C; Pycha A
    World J Urol; 2012 Dec; 30(6):841-6. PubMed ID: 23143733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
    Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
    BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.